WuXi MedKey
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
WuXi MedKey - overview
Established
2009
Location
Shanghai, Shanghai, China
Primary Industry
Healthcare
About
Based in Shanghai, China and founded in 2009, WuXi MedKey Med‑Tech Development (Shanghai) Co. , Ltd. , trading under the name WuXi MedKey, focuses on providing clinical research support services. The company has developed a nationwide network across more than 150 cities and supports clinical studies across multiple therapeutic areas.
Over time, it has accumulated experience in thousands of clinical research projects and established collaborations with hospitals and research institutions. In December 2025, Hillhouse Investment fully acquired the company. The company works with pharmaceutical and medical device companies to provide clinical trial support services. Its offerings include site management services (SMO), clinical trial execution support, study startup services, quality control and auditing services, and investigator training programs such as GCP training.
The company supports clinical studies across therapeutic areas including oncology, cardiovascular diseases, neurology, and immunology. The company generates revenue from providing clinical trial support services, site management services, and outsourcing solutions to pharmaceutical and medical device companies.
Current Investors
Hillhouse Investment
Primary Industry
Healthcare
Sub Industries
Biopharmaceuticals, Healthcare, Healthcare Specialists
Website
https://smo.wuxiapptec.com/
Verticals
HealthTech
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
WuXi MedKey - financials
| Fiscal Year Ended | Dec 31, 2024 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
WuXi MedKey - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | WuXi MedKey | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.